Inventor · disambiguated record
Ricardo Attar
Also filed as: ATTAR RICARDO · ATTAR RICARDO M · ATTAR RICARDO MARCOS · LEE LIANA M
24 granted patents·14 pending applications·350 citations·filing 1998–2024
96Inventor score
Files withJANSSEN BIOTECH INC13BRISTOL MYERS SQUIBB CO9JANSSEN PHARMACEUTICA NV7CAMPHAUSEN RAY2HUANG FEI1
Top patents by PatentIndex Score
38 records- 0196US8221765B2Multivalent fibronectin based scaffold domain proteinsCAMPHAUSEN RAY·Filed 2009·Granted Jul 17, 2012·66 cites·20 claims
- 0295US10072088B2Anti-BCMA antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Sep 11, 2018·30 cites·16 claims
- 0395US9902762B2Multivalent fibronectin based scaffold domain proteinsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 27, 2018·28 cites·10 claims
- 0495US8728483B2Multivalent fibronectin based scaffold domain proteinsCAMPHAUSEN RAY·Filed 2012·Granted May 20, 2014·38 cites·29 claims
- 0595US6960474B2Method for the treatment of a condition remediable by administration of a selective androgen receptor modulatorBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 1, 2005·82 cites·8 claims
- 0692US10774130B2Method of treating cancer by administering multivalent fibronectin based scaffold domain proteinsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 15, 2020·6 cites·15 claims
- 0792US10562968B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 18, 2020·18 cites·19 claims
- 0892US9850310B2CD123 binding agents and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Dec 26, 2017·23 cites·20 claims
- 0991US12077592B2GPRC5D chimeric antigen receptors and cells expressing the sameJANSSEN BIOTECH INC·Filed 2020·Granted Sep 3, 2024·3 cites·36 claims
- 1090US9695228B2EGFR and c-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2013·Granted Jul 4, 2017·15 cites·9 claims
- 1189US11884722B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Granted Jan 30, 2024·1 cites·25 claims
- 1289US10662235B2Cysteine engineered fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2017·Granted May 26, 2020·4 cites·15 claims
- 1383US9725497B2EGFR and C-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2013·Granted Aug 8, 2017·5 cites·13 claims
- 1481US11685777B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 27, 2023·1 cites·9 claims
- 1581US7655688B2Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 2, 2010·5 cites·8 claims
- 1678US8492328B2Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulatorsHUANG FEI·Filed 2008·Granted Jul 23, 2013·4 cites·7 claims
- 1778US2024343796A1Anti- gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1878US2024262921A1Gprc5d chimeric antigen receptors and cells expressing the sameJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1977US6795776B1Crystallographic structure of the androgen receptor ligand binding domainBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Sep 21, 2004·12 cites·3 claims
- 2075US7199227B2Polynucleotides encoding human histone deacetylase HDAC9cBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 3, 2007·3 cites·14 claims
- 2174US12304939B2EGFR and C-met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2021·Granted May 20, 2025·0 cites·8 claims
- 2270US10106620B2Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cellsUS HEALTH·Filed 2015·Granted Oct 23, 2018·3 cites·27 claims
- 2370US2021017252A1Multivalent fibronectin based scaffold domain proteinsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2468US2024294884A1Vaccines based on mutant calr and jak2 and their usesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 2565US10954284B2EGFR and c-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2017·Granted Mar 23, 2021·0 cites·6 claims
- 2659US12018289B2Vaccines based on mutant CALR and JAK2 and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Jun 25, 2024·0 cites·26 claims
- 2758US2020325210A1Cysteine engineered fibronectin type iii domain binding moleculesJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 2857US2022267438A1Trispecific antibody targeting bcma, gprc5d, and cd3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2953US2005075358A1Methods for treating IGF1R-inhibitor induced hyperglycemiaFiled 2004·Application pending·0 cites
- 3051US7225083B2Crystallographic structure of the androgen receptor ligand binding domainBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 29, 2007·0 cites·8 claims
- 3148US2019270826A1Anti-il1rap antibodies, bispecific antigen binding molecules that bind il1rap and cd3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 3248US2005256048A1Selective androgen receptor modulators and methods for their identification, design and useSALVATI MARK E·Filed 2005·Application pending·0 cites
- 3346US2004087548A1Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionFiled 2002·Application pending·0 cites
- 3441US2004068762A1Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elementsFiled 2003·Application pending·0 cites
- 3541US2017121420A1Anti-il1rap antibodies, bispecific antigen binding molecules that bind il1rap and cd3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3638US2011123545A1Combination of vegfr2 and igf1r inhibitors for the treatment of proliferative diseasesBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 3737US2017210799A1Anti-ror1, antibodies, ror1 x cd3 bispecific antibodies, and methods of using the sameJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 3826US6479237B1Methods for detecting interaction among several proteinsINST NAT SANTE RECH MED·Filed 1998·Granted Nov 12, 2002·3 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Ricardo Attar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →